C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/4439 (2006.01) A61P 1/04 (2006.01) A61P 1/06 (2006.01) A61P 1/18 (2006.01) A61P 11/06 (2006.01) A61P 13/12 (2006.01) A61P 17/00 (2006.01) A61P 17/06 (2006.01) A61P 19/02 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/02 (2006.01) A61P 37/06 (2006.01) A61P 37/08 (2006.01) A61P 39/00 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2495437
Crystals of 4,6-dimethyl-4~-~3,5-bis(trifluoromethyl)-1H-pyrazol-1- yl~nicotinanilide having an excellent calcium release-dependent calcium channel inhibitory effect and an excellent IL-2 production inhibitory activity are obtained. It is found out that this compound occurs in two crystal polymorphisms both of which are appropriate as starting materials for producing medicinal compositions.
L'invention porte sur des cristaux de 4,6-diméthyl-4'-Ý3,5-bis(trifluorométhyl)-1H-pyrazol-1-yl¨nicotinanilide présentant un fort effet inhibiteur des canaux calciques dépendant de la libération du calcium, et une excellente activité inhibitrice de la production d'IL-2. Il est apparu que ce composé présente deux polymorphismes de cristaux pouvant tous deux constituer des matériaux de départ de compositions médicales
Iwaoka Kiyoshi
Kubota Hirokazu
Yamaguchi Sou
Yokota Masaki
Astellas Pharma Inc.
Dennison Associates
Yamanouchi Pharmaceutical Co. Ltd.
LandOfFree
Novel crystal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel crystal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel crystal will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1762502